Baxter acquiring gene-therapy firm

Share this article:

Almost a week after announcing Baxter was going to break into two divisions, the Illinois company is already expanding.

Crain's Chicago Business reports that the company is buying up partner Chatham Therapeutics for $70 million.

Crain's notes that the $70-million deal may not be an all-in-one payment and that Baxter may provide the gene therapy company milestone payments even after the purchase.

Share this article:
You must be a registered member of MMM to post a comment.

This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.